Role of nitric oxide in murine conventional outflow physiology

American Journal of Physiology - Cell Physiology

Volumn 309, Issue 4, 2015, Pages C205-C214

  Chang, Jason Y H ^a,b   Daniel Stamer, W ^b   Bertrand, Jacques ^a   Thomas Read, A ^c   Marando, Catherine M ^a   Ross Ethier, C ^a,d   Overby, Darryl R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Emory University   (United States)

Author keywords

Aqueous humor outflow; Glaucoma; Intraocular pressure; Mouse model; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GREEN FLUORESCENT PROTEIN; N ACETYL S NITROSOPENICILLAMINE; N ACETYLPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NOS3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; GLAUCOMA; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCHLEMM CANAL; TRANSGENIC MOUSE; ANIMAL; AQUEOUS HUMOR; C57BL MOUSE; FEMALE; HUMAN; MALE; METABOLISM;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; AQUEOUS HUMOR; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84939554314     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00347.2014     Document Type: Article

References (78)

1. Alvarado JA, Katz LJ, Trivedi S, Shifera AS. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Arch Ophthalmol 128: 731–737, 2010.
2. Ashpole NE, Overby DR, Ethier CR, Stamer WD. Shear stress-triggered nitric oxide release from Schlemm’s canal cells. Invest Ophthalmol Vis Sci 55: 8067–8076, 2014.
3. Aspelund A, Tammela T, Antila S, Nurmi H, Leppänen VM, Zarkada G, Stanczuk L, Francois M, Mäkinen T, Saharinen P, Immonen I, Alitalo K. The Schlemm’s canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J Clin Invest 124: 3975–3986, 2014.
4. Bachmann B, Birke M, Kook D, Eichhorn M, Lütjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci 47: 2011–2020, 2006.
5. Barany E. The mode of action of pilocarpine on outflow resistance in the eye of a primate (Cercopithecus ethiops). Invest Ophthalmol 1: 712–727, 1962.
6. Beauregard C, Liu Q, Chiou G. Effects of nitric oxide donors and nitric oxide synthase substrates on ciliary muscle contracted by carbachol and endothelin for possible use in myopia prevention. J Ocul Pharmacol Ther 17: 1–9, 2001.
7. Borghi V, Bastia E, Guzzetta M, Chiroli V, Toris CB, Batugo MR, Carreiro ST, Chong WK, Gale DC, Kucera DJ, Jia L, Prasanna G, Ongini E, Krauss AH, Impagnatiello F. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma. J Ocul Pharmacol Ther 26: 125–132, 2010.
8. Boussommier-Calleja A, Bertrand J, Woodward DF, Ethier CR, Stamer WD, Overby DR. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. Invest Ophthalmol Vis Sci 53: 5838–5845, 2012.
9. Boussommier-Calleja A, Overby DR. The influence of genetic background on conventional outflow facility in mice. Invest Ophthalmol Vis Sci 54: 8251–8258, 2013.
10. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6: 1362-1367, 2000.
11. Buxton IL, Cheek DJ, Eckman D, Westfall DP, Sanders KM, Keef KD. NG-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 72: 387–395, 1993.
12. Buys ES, Ko YC, Alt C, Hayton SR, Jones A, Tainsh LT, Ren R, Giani A, Clerté M, Abernathy E, Tainsh RET, Oh DJ, Malhotra R, Arora P, de Waard N, Yu B, Turcotte R, Nathan D, Scherrer-Crosbie M, Loomis SJ, Kang JH, Lin CP, Gong H, Rhee DJ, Brouckaert P, Wiggs JL, Gregory MS, Pasquale LR, Bloch KD, Ksander BR. Soluble guanylate cyclase 1-deficient mice: a novel murine model for primary open angle glaucoma. PLos One 8: e60156, 2013.
13. Chang YS, Yaccino JA, Lakshminarayanan S, Frangos JA, Tarbell JM. Shear-induced increase in hydraulic conductivity in endothelial cells is mediated by a nitric oxide-dependent mechanism. Arterioscler Thromb Vasc Biol 20: 35–42, 2000.
14. Cheng C, van Haperen R, de Waard M, van Damme LC, Tempel D, Hanemaaijer L, van Cappellen GW, Bos J, Slager CJ, Duncker DJ, van der Steen AF, de Crom R, Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 106: 3691–3698, 2005.
15. Condorelli P, George SC. In vivo control of soluble guanylate cyclase activation by nitric oxide: a kinetic analysis. Biophys J 80: 2110–2119, 2001.
16. David R, Zangwill L, Stone D, Yassur Y. Epidemiology of intraocularpressure in a population screened for glaucoma. Br J Ophthalmol 71: 766–771, 1987.
17. de Kater AW, Spurr-Michaud SJ, Gipson IK. Localization of smooth muscle myosin-containing cells in the aqueous outflow pathway. Invest Ophthalmol Vis Sci 31: 347–353, 1990.
18. Di Lorenzo A, Lin MI, Murata T, Landskroner-Eiger S, Schleicher M, Kothiya M, Iwakiri Y, Yu J, Huang PL, Sessa WC. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases. J Cell Sci 126: 5541–5552, 2013.
19. Dismuke WM, Ellis DZ. Activation of the BKCa channel increases outflow facility and decreases trabecular meshwork cell volume. J Ocul Pharmacol Ther 25: 309–314, 2009.
20. Dismuke WM, Liang J, Overby DR, Stamer WD. Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res 120: 28–35, 2014.
21. Dismuke WM, Mbadugha CC, Ellis DZ. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am J Physiol Cell Physiol 294: C1378–C1386, 2008.
22. Ellis DZ, Dismuke WM, Chokshi BM. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork. Invest Ophthalmol Vis Sci 50: 1808–1813, 2009.
23. Ellis DZ, Sharif NA, Dismuke WM. Endogenous regulation of human Schlemm’s canal cell volume by nitric oxide signaling. Invest Ophthalmol Vis Sci 51: 5817–5824, 2010.
24. Ethier CR, Read AT, Chan D. Biomechanics of Schlemm’s canal endothelial cells: influence on F-actin architecture. Biophys J 87: 2828-2837, 2004.
25. Funk RH, Mayer B, Wörl J. Nitrergic innervation and nitrergic cells in arteriovenous anastomoses. Cell Tissue Res 277: 477–484, 1994.
26. Gabelt BT, Kaufman PL, Rasmussen CA. Effect of nitric oxide compounds on monkey ciliary muscle in vitro. Exp Eye Res 93: 321–327, 2011.
27. Gil DW, Krauss HA, Bogardus AM, WoldeMussie E. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest Ophthalmol Vis Sci 38: 1434–1442, 1997.
28. Goh Y, Hotehama Y, Mishima HK. Characterization of ciliary musclerelaxation induced by various agents in cats. Invest Ophthalmol Vis Sci 36: 1188–1192, 1995.
29. Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZJ, Fairchild TA, Iwakiri Y, Groszmann R, Claffey KP, Cheng YC, Sessa WC. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 4: 31–39, 2003.
30. Hamanaka T, Bill A, Ichinohasama R, Ishida T. Aspects of the development of Schlemm’s canal. Exp Eye Res 55: 479–488, 1992.
31. Heimark RL, Kaochar S, Stamer WD. Human Schlemm’s canal cells express the endothelial adherens proteins, VE-cadherin and PECAM-1. Curr Eye Res 25: 299–308, 2002.
32. Heyne GW, Kiland JA, Kaufman PL, Gabelt BT. Effect of nitric oxide on anterior segment physiology in monkeys. Invest Ophthalmol Vis Sci 54: 5103–5110, 2013.
33. Johnson MC, Kamm RD. The role of Schlemm’s canal in aqueous outflow from the human eye. Invest Ophthalmol Vis Sci 24: 320–325, 1983.
34. Kang JH, Wiggs JL, Rosner BA, Hankinson SE, Abdrabou W, Fan BJ, Haines J, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 51: 971–979, 2010.
35. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res 69: 413–429, 1999.
36. Kizhatil K, Ryan M, Marchant JK, Henrich S, John SW. Schlemm’s canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLos Biol 12: e1001912, 2014.
37. Klein B, Klein R, Linton K. Intraocular-pressure in an American community— the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 33: 2224–2228, 1992.
38. Kotikoski H, Vapaatalo H, Oksala O. Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits. Curr Eye Res 26: 119–123, 2003.
39. Krupin T, Weiss A, Becker B, Holmberg N, Fritz C. Increased intraocular- pressure following topical azide or nitroprusside. Invest Ophthalmol Vis Sci 16: 1002–1007, 1977.
40. Lei Y, Overby DR, Boussommier-Calleja A, Stamer WD, Ethier CR. Outflow physiology of the mouse eye: pressure dependence and washout. Invest Ophthalmol Vis Sci 52: 1865–1871, 2011.
41. Lei Y, Stamer WD, Wu J, Sun X. Endothelial nitric oxide synthaserelated mechanotransduction changes in aged porcine angular aqueous plexus cells. Invest Ophthalmol Vis Sci 55: 8402–8408, 2014.
42. Li G, Farsiu S, Chiu SJ, Gonzalez P, Lütjen-Drecoll E, Overby DR, Stamer WD. Pilocarpine-induced dilation of Schlemm’s canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT. Invest Ophthalmol Vis Sci 55: 3737–3746, 2014.
43. Logan J, Chakravarthy U, Hughes AE, Patterson CC, Jackson JA, Rankin S. Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci 46: 3221–3226, 2005.
44. May CA, Fuchs AV, Scheib M, Lütjen-Drecoll E. Characterization of nitrergic neurons in the porcine and human ciliary nerves. Invest Ophthalmol Vis Sci 43: 581–586, 2002.
45. May CA, Skorski LM, Lütjen-Drecoll E. Innervation of the porcine ciliary muscle and outflow region. J Anat 206: 231–236, 2005.
46. Millar JC, Clark AF, Pang IH. Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion. Invest Ophthalmol Vis Sci 52: 685–694, 2011.
47. Millard LH, Woodward DF, Stamer WD. The role of the prostaglandin EP4 receptor in the regulation of human outflow facility. Invest Ophthalmol Vis Sci 52: 3506–3513, 2011.
48. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 36: 1765–1773, 1995.
49. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther 260: 956–965, 1992.
50. Overby D, Gong HY, Qiu GT, Freddo TF, Johnson M. The mechanism of increasing outflow facility during washout in the bovine eye. Invest Ophthalmol Vis Sci 43: 3455–3464, 2002.
51. Overby DR, Bertrand J, Schicht M, Paulsen F, Stamer WD, Lütjen- Drecoll E. The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice. Invest Ophthalmol Vis Sci 55: 3727–3736, 2014.
52. Park DY, Lee J, Park I, Choi D, Lee S, Song S, Hwang Y, Hong KY, Nakaoka Y, Mäkinen T. Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity. J Clin Invest 124: 3960, 2014.
53. Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol 118: 1433–1440, 1996.
54. Polak K, Luksch A, Berisha F, Fuchsjaeger-Mayrl G, Dallinger S, Schmetterer L. Altered nitric oxide system in patients with open-angle glaucoma. Arch Ophthalmol 125: 494–498, 2007.
55. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289: L371–L381, 2005.
56. Ramos RF, Hoying JB, Witte MH, Daniel Stamer W. Schlemm’s canal endothelia, lymphatic, or blood vasculature? J Glaucoma 16: 391–405, 2007.
57. 56a. Rogers NM, Isenberg JS. Seeing is believing: NO therapy for glaucoma? Focus on “Role of nitric oxide in murine conventional outflow physiology.” Am J Physiol Cell Physiol (June 24, 2015). doi:10.1152/ajpcell. 00180.2015.
58. Rohen JW, Futa R, Lütjen-Drecoll E. The fine-structure of the cribriform meshwork in normal and glaucomatous eyes as seen in tangential sections. Invest Ophthalmol Vis Sci 21: 574–585, 1981.
59. Rohen JW, Lütjen-Drecoll E, Barany E. The relation between the ciliary muscle and the trabecular meshwork and its importance for the effect of miotics on aqueous outflow resistance. A study in two contrasting monkey species, Macaca irus and Cercopithecus aethiops. Arch Clin Exp Ophthalmol 172: 23–47, 1967.
60. Rosenquist R, Epstein DL, Melamed S, Johnson M, Grant WM. Outflow resistance of enucleated human eyes at 2 different perfusion pressures and different extents of trabeculotomy. Curr Eye Res 8: 1233–1240, 1989.
61. Schmitz M, Zerr I, Althaus HH. Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades. Cell Mol Neurobiol 31: 991–997, 2011.
62. Schneemann A, Dijkstra BG, van den Berg TJ, Kamphuis W, Hoyng PF. Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion. Arch Clin Exp Ophthalmol 240: 936–941, 2002.
63. Schneemann A, Leusink-Muis A, van den Berg T, Hoyng PF, Kamphuis W. Elevation of nitric oxide production in human trabecular meshwork by increased pressure. Arch Clin Exp Ophthalmol 241: 321–326, 2003.
64. Schuman JS, Erickson K, Nathanson JA. Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 58: 99–105, 1994.
65. Selbach JM, Gottanka J, Wittmann M, Lütjen-Drecoll Efferent E. Afferent innervation of primate trabecular meshwork and scleral spur. Invest Ophthalmol Vis Sci 41: 2184–2191, 2000.
66. Sellers SL, Trane AE, Bernatchez PN. Caveolin as a potential drug target for cardiovascular protection. Front Physiol 3: 280, 2012.
67. Shahidullah M, Yap M, To CH. Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye. Br J Pharmacol 145: 84–92, 2005.
68. Smith RS, John SW, Nishina PM, Sundberg JP. Systematic Evaluation of the Mouse Eye. Boca Raton, FL: CRC, 2001.
69. Stamer WD, Acott TS. Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 23: 135–143, 2012.
70. Stamer WD, Lei Y, Boussommier-Calleja A, Overby DR, Ethier CR. eNOS, a pressure-dependent regulator of intraocular pressure. Invest Ophthalmol Vis Sci 52: 9438–9444, 2011.
71. Stamer WD, Perkumas KM, Hoffman EA, Roberts BC, Epstein DL, McKay BS. Coiled-coil targeting of myocilin to intracellular membranes. Exp Eye Res 83: 1386–1395, 2006.
72. Sumida GM, Stamer WD. S1P receptor regulation of sphingosine-1- phosphate effects on conventional outflow physiology. Am J Physiol Cell Physiol 300: C1164–C1171, 2011.
73. Tektas O, Lütjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res 88: 769–775, 2009.
74. Tinker AC, Beaton HG, Boughton-Smith N, Cooper SL, Fraser-Rae L, Hallam K, Hamley P, McInally T, Nicholls DJ, Pimm AD, Wallace AV. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show anti-inflammatory activity in vivo. J Med Chem 46: 913–916, 2003.
75. van Haperen R, Cheng C, Mees B, van Deel E, de Waard M, van Damme L, van Gent T, van Aken T, Krams R, Duncker DJ, de Crom R. Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice. Am J Pathol 163: 1677–1686, 2003.
76. Wiederholt M, Sturm A, Lepplewienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric-oxide. Invest Ophthalmol Vis Sci 35: 2515–2520, 1994.
77. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225–228, 1992.
78. Zamora DO, Kiel JW. Episcleral venous pressure responses to topical nitroprusside and N-nitro-L-arginine methyl ester. Invest Ophthalmol Vis Sci 51: 1614–1620, 2010.